Article Text

PDF
Original research
Contribution of whole platelet aggregometry to the endovascular management of unruptured aneurysms: an institutional experience
  1. S G Aoun,
  2. B G Welch,
  3. L G Pride,
  4. J White,
  5. R Novakovic,
  6. K Hoes,
  7. R Sarode
  1. Departments of Neurosurgery, Radiology, and Pathology, The University of Texas Southwestern, Dallas, Texas, USA
  1. Correspondence to Dr B G Welch, Departments of Neurosurgery, Radiology, and Pathology, The University of Texas Southwestern, 5161 Harry Hines Boulevard, CS5.112, Dallas, TX 75235, USA; babu.welch{at}utsouthwestern.edu

Abstract

Background Stent-assisted coiling of intracranial aneurysms is an efficient alternative treatment to surgical clipping but requires prolonged antiplatelet therapy. Some patients are non-responsive to aspirin and/or clopidogrel.

Objective To analyze the implications of this assessment using the ‘whole blood aggregometry (WBA) by impedance’ technique.

Materials and methods The Southwestern Tertiary Aneurysm Registry was reviewed between 2002 and 2012 for patients with unruptured aneurysms treated with stent-assisted coiling. The study population was divided into patients who were tested preoperatively for platelet responsiveness to aspirin and clopidogrel (‘tested’ patients) and those who were not (‘non-tested’). Where necessary, tested patients received additional doses of antiplatelet drugs to achieve adequate platelet inhibition. Endpoints included the incidence of non-responsiveness, the rates of thrombotic and hemorrhagic complications, and the rates of permanent morbidity and mortality.

Results A total of 266 patients fulfilled our selection criteria: 114 non-tested patients who underwent 121 procedures, and 152 tested patients who underwent 171 procedures. The two groups did not vary significantly in patient age, gender, and aneurysms location. Aspirin non-responsiveness was detected in 3 patients (1.75%) and clopidogrel non-responsiveness in 21 patients (12.3%). Non-tested patients had an 11.6% rate of thrombotic complications with a 4.1% permanent morbidity or mortality rate versus 2.3% and 0.6% in tested patients (p=0.0013). The incidence of hemorrhagic complications was similar between the two groups.

Conclusions Preoperative platelet inhibition testing using WBA can be useful to assess and correct antiaggregant non-responsiveness, and may reduce postoperative mortality and permanent morbidity.

  • Aneurysm
  • Angiography
  • Stent
  • Stroke
  • Complication

Statistics from Altmetric.com

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.